Aumed, a.s., Komořanská 326/63, 143 14 Praha - Modřany, Česká republika

+420 603 587 701 English

“COVID-19” TESTING FOR COMPANIES

kit aktuality

AUMED a.s. offers for companies a comprehensive solution for preventive testing of the SARS-CoV-2 virus (COVID-19). We provide sampling and subsequent testing of samples. We perform sampling with the PCR GARGLING KIT, the principle of which is based on gargling of the oral cavity and pharynx. The collection is therefore much more pleasant and completely painless. Instead of pushing the sticks into the nose, it is enough to gargle a sip of ordinary water for 20-30 seconds for half a minute and then empty this content from the mouth into the enclosed collection tube containing the transport powder. The evaluation is then performed by our newly developed test kit using the RT-LAMP method. The RT-LAMP test is functionally comparable to the RT-PCR test. For long-term and effective protection of the company, therefore, a significantly longer interval of repeated testing will suffice than in the case of antigen tests, where retestation occurs every 5 days! This makes our testing more cost-effective than inaccurate antigen testing. We send the results within 6-8 hours after receiving the samples. If you are interested, please contact us at info@aumed.cz.

MORE ARTICLES

Successful completion of the TRIO project „Development of a new dosage form for oral vaccine administration”

18. 05. 2022

AUMED, a.s. successfully completed a multi-year project of the research and development support program of the Ministry of Industry and…

AUMED, a.s. received a grant for the Innovation Project entitled “TFI Transfer Factor – Medicine”

18. 05. 2022

AUMED, a.s. received a grant in the Operational Program Enterprise and Innovation for Competitiveness under the Innovation Call – Innovation…

PCR GARGLING KIT

07. 05. 2021

AUMED, a.s. launches its own self-sampling set based on the principle of gargling of the oral cavity and pharynx. The…

Research projects of Aumed, a.s. are financed by the European Structural Funds:
Research and development of a new pertussis vaccine
Transfer factor — research and development of a new medical form
Production of diagnostic kit for covid-19 on the lamp principle
TFI Transfer Factor – Medicine

and with financial support from the state budget through the Ministry of Industry and Trade in the TRIO program:
Research and development of a new oral administration of vaccine

European Union
European Regional Development Fund
OP Enterprise and Innovation for Competitiveness


Tel.: +420 603 587 701
Komořanská 326/63, 143 14 Praha - Modřany, Česká republika
(c) 2017, Aumed a.s